Medullary Thyroid Carcinoma and Population Screening-The Promise and Pitfalls of Genetic Testing

被引:4
|
作者
Davies, Louise [1 ,2 ,3 ,6 ]
Angelos, Peter [4 ,5 ]
机构
[1] VA Outcomes Grp, Dept Vet Affairs Med Ctr, White River Jct, VT USA
[2] Geisel Sch Med Dartmouth, Sect Otolaryngol Head & Neck Surg, New Hampshire, Hanover, Jamaica
[3] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, New Hampshire, Hanover, Jamaica
[4] Univ Chicago, Dept Surg, Sect Gen Surg & Surg Oncol, Chicago, IL USA
[5] Univ Chicago, MacLean Ctr Clin Med Ethics, Chicago, IL USA
[6] VA Outcomes Grp, Dept Vet Affairs Med Ctr, 215 N Main St,111B, White River Jct, VT 05009 USA
关键词
D O I
10.1001/jamaoto.2022.4196
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
收藏
页码:202 / 203
页数:2
相关论文
共 50 条
  • [21] Miscarriage After Noninvasive Prenatal Screening-The Value of Genetic Testing in Pregnancy Loss
    Maisenbacher, Melissa
    DiNonno, Wendy
    Merrion, Katrina
    Young, Michael
    Sigurjonsson, Styrmir
    Hedriana, Herman
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 118S - 118S
  • [23] Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease
    Herrmann, B. L.
    Schmid, K. W.
    Goerges, R.
    Kemen, M.
    Mann, K.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (06) : 1141 - 1145
  • [24] GENETIC SCREENING OF ENDOCRINE TUMOR SYNDROMES WITH DNA PROBES - THE EXAMPLE OF MEDULLARY-THYROID CARCINOMA
    SOBOL, H
    NAROD, SA
    ASSOULINE, D
    LENOIR, GM
    HORMONE RESEARCH, 1989, 32 (1-3) : 34 - 40
  • [25] SCREENING FOR ADRENAL-MEDULLARY DISEASE IN PATIENTS WITH MEDULLARY-THYROID CARCINOMA
    BONNIN, F
    SCHLUMBERGER, M
    GARDET, P
    TENENBAUM, F
    LUMBROSO, J
    LECLERE, J
    COMOY, E
    MEGNIGBETO, A
    TRAVAGLI, JP
    PARMENTIER, C
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (04) : 253 - 257
  • [26] PENTAGASTRIN STIMULATION TEST AND EARLY DIAGNOSIS OF MEDULLARY-THYROID CARCINOMA USING AN IMMUNORADIOMETRIC ASSAY OF CALCITONIN - COMPARISON WITH GENETIC SCREENING IN HEREDITARY MEDULLARY-THYROID CARCINOMA
    BARBOT, N
    CALMETTES, C
    SCHUFFENECKER, I
    SAINTANDRE, JP
    FRANC, B
    ROHMER, V
    JALLET, P
    BIGORGNE, JC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (01): : 114 - 120
  • [27] The genetic background of medullary thyroid carcinoma in young patients
    Wiench, M
    Wygoda, Z
    Gubala, E
    Wloch, J
    Oczko, M
    Jarzab, B
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 : 163 - 164
  • [28] The genetic aspects of medullary thyroid carcinoma: Recognition and management
    Williamson, P
    Ponder, B
    Church, S
    Fiddler, M
    Harris, R
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1996, 30 (05): : 443 - 447
  • [29] Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
    Carolien M. Beukhof
    Tessa Brabander
    Francien H. van Nederveen
    Marie-Louise F. van Velthuysen
    Yolanda B. de Rijke
    Leo J. Hofland
    Gaston J. H. Franssen
    Lideke A. C. Fröberg
    Boen L. R. Kam
    W. Edward Visser
    Wouter W. de Herder
    Robin P. Peeters
    BMC Cancer, 19
  • [30] Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
    Beukhof, Carolien M.
    Brabander, Tessa
    van Nederveen, Francien H.
    van Velthuysen, Marie-Louise F.
    de Rijke, Yolanda B.
    Hofland, Leo J.
    Franssen, Gaston J. H.
    Froberg, Lideke A. C.
    Kam, Boen L. R.
    Visser, W. Edward
    de Herder, Wouter W.
    Peeters, Robin P.
    BMC CANCER, 2019, 19 (1)